Fighting genetic disorders is a new frontier in the field of medicine today. While some of them can be managed by early interventions, most genetic disorders do not yet have a cure.  Scientists all over the world are trying new drugs and techniques to understand and rectify such disorders. In a recent study, scientists have used bone marrow stem cell transplant as a promising cure to Alpha-1 antitrypsin deficiency (AATD), a genetic disorder affecting one in 3000. The stem cell therapy, tested on mice, has yielded a positive result and the researchers hope this could be a new ray of hope for patients with AATD.